Cargando…

The antibiotic resistance of Helicobacter pylori to five antibiotics and influencing factors in an area of China with a high risk of gastric cancer

BACKGROUND: H. pylori exhibits antibiotic resistance with regional differences. In this paper, we explored antibiotic resistance of H. pylori to five antibiotics in an area with a high risk of gastric cancer. RESULTS: H. pylori resistance rates to metronidazole, levofloxacin, clarithromycin, amoxici...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Dan, Guo, Qianqian, Yuan, Yuan, Gong, Yuehua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611032/
https://www.ncbi.nlm.nih.gov/pubmed/31272365
http://dx.doi.org/10.1186/s12866-019-1517-4
_version_ 1783432616661221376
author Wang, Dan
Guo, Qianqian
Yuan, Yuan
Gong, Yuehua
author_facet Wang, Dan
Guo, Qianqian
Yuan, Yuan
Gong, Yuehua
author_sort Wang, Dan
collection PubMed
description BACKGROUND: H. pylori exhibits antibiotic resistance with regional differences. In this paper, we explored antibiotic resistance of H. pylori to five antibiotics in an area with a high risk of gastric cancer. RESULTS: H. pylori resistance rates to metronidazole, levofloxacin, clarithromycin, amoxicillin, and tetracycline were 78.0, 56.0, 31.0, 9.0, and 15.0%, respectively. Double, triple, quadruple, and quintuple resistance rates were 23, 20, 6, and 4%, respectively. The clarithromycin and multidrug resistance rates were significantly higher in males than females (clarithromycin: 44.4% vs 15.2%, respectively, P = 0.002; multidrug: 75.5% vs 37.2%, respectively; P < 0.001). During the three periods of 1998–1999, 2002–2004 and 2016–2017, the resistance rates to levofloxacin and amoxicillin were increasing (OR: 2.089, 95%CI: 1.142–3.821, P = 0.017; and OR: 5.035, 95%CI: 1.327–19.105, P = 0.018, respectively). The antibiotic resistance rates were unassociated with the host disease state. Metronidazole resistance was lower in the vacAs1m1/m2 group than the vacAs1m1m2 group (65% vs 85.7%, respectively; P = 0.026). As for levofloxacin resistance, it was higher with cagA (+) than cagA(−) (60.9% vs 23.1%, respectively; P = 0.020) but lower with slyD(+) than slyD(−) (41.4% vs 68.5%, respectively; P = 0.009). Clarithromycin had a lower resistance rate with iceA(++) than iceA(−+) (19.7% vs 52.4%, respectively; P = 0.017). For amoxicillin, the iceA(++) group had a lower resistance rate than the iceA(−−) group (1.6% vs 27.8%, respectively; P = 0.009). CONCLUSIONS: The total resistance rates of H. pylori to metronidazole, levofloxacin, clarithromycin, amoxicillin, and tetracycline were high in Zhuanghe. The resistanc rates to levofloxacin and amoxicillin increased over time. Clarithromycin resistance was associated with male and iceA. The resistance of metronidazole was related to vacA. Levofloxacin resistance was concerned with cagA and slyD and amoxicillin resistance was concerned with iceA. While, the antibiotic resistance of H. pylori had nothing to do with the status of gastric disease.
format Online
Article
Text
id pubmed-6611032
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66110322019-07-16 The antibiotic resistance of Helicobacter pylori to five antibiotics and influencing factors in an area of China with a high risk of gastric cancer Wang, Dan Guo, Qianqian Yuan, Yuan Gong, Yuehua BMC Microbiol Research Article BACKGROUND: H. pylori exhibits antibiotic resistance with regional differences. In this paper, we explored antibiotic resistance of H. pylori to five antibiotics in an area with a high risk of gastric cancer. RESULTS: H. pylori resistance rates to metronidazole, levofloxacin, clarithromycin, amoxicillin, and tetracycline were 78.0, 56.0, 31.0, 9.0, and 15.0%, respectively. Double, triple, quadruple, and quintuple resistance rates were 23, 20, 6, and 4%, respectively. The clarithromycin and multidrug resistance rates were significantly higher in males than females (clarithromycin: 44.4% vs 15.2%, respectively, P = 0.002; multidrug: 75.5% vs 37.2%, respectively; P < 0.001). During the three periods of 1998–1999, 2002–2004 and 2016–2017, the resistance rates to levofloxacin and amoxicillin were increasing (OR: 2.089, 95%CI: 1.142–3.821, P = 0.017; and OR: 5.035, 95%CI: 1.327–19.105, P = 0.018, respectively). The antibiotic resistance rates were unassociated with the host disease state. Metronidazole resistance was lower in the vacAs1m1/m2 group than the vacAs1m1m2 group (65% vs 85.7%, respectively; P = 0.026). As for levofloxacin resistance, it was higher with cagA (+) than cagA(−) (60.9% vs 23.1%, respectively; P = 0.020) but lower with slyD(+) than slyD(−) (41.4% vs 68.5%, respectively; P = 0.009). Clarithromycin had a lower resistance rate with iceA(++) than iceA(−+) (19.7% vs 52.4%, respectively; P = 0.017). For amoxicillin, the iceA(++) group had a lower resistance rate than the iceA(−−) group (1.6% vs 27.8%, respectively; P = 0.009). CONCLUSIONS: The total resistance rates of H. pylori to metronidazole, levofloxacin, clarithromycin, amoxicillin, and tetracycline were high in Zhuanghe. The resistanc rates to levofloxacin and amoxicillin increased over time. Clarithromycin resistance was associated with male and iceA. The resistance of metronidazole was related to vacA. Levofloxacin resistance was concerned with cagA and slyD and amoxicillin resistance was concerned with iceA. While, the antibiotic resistance of H. pylori had nothing to do with the status of gastric disease. BioMed Central 2019-07-04 /pmc/articles/PMC6611032/ /pubmed/31272365 http://dx.doi.org/10.1186/s12866-019-1517-4 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Wang, Dan
Guo, Qianqian
Yuan, Yuan
Gong, Yuehua
The antibiotic resistance of Helicobacter pylori to five antibiotics and influencing factors in an area of China with a high risk of gastric cancer
title The antibiotic resistance of Helicobacter pylori to five antibiotics and influencing factors in an area of China with a high risk of gastric cancer
title_full The antibiotic resistance of Helicobacter pylori to five antibiotics and influencing factors in an area of China with a high risk of gastric cancer
title_fullStr The antibiotic resistance of Helicobacter pylori to five antibiotics and influencing factors in an area of China with a high risk of gastric cancer
title_full_unstemmed The antibiotic resistance of Helicobacter pylori to five antibiotics and influencing factors in an area of China with a high risk of gastric cancer
title_short The antibiotic resistance of Helicobacter pylori to five antibiotics and influencing factors in an area of China with a high risk of gastric cancer
title_sort antibiotic resistance of helicobacter pylori to five antibiotics and influencing factors in an area of china with a high risk of gastric cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611032/
https://www.ncbi.nlm.nih.gov/pubmed/31272365
http://dx.doi.org/10.1186/s12866-019-1517-4
work_keys_str_mv AT wangdan theantibioticresistanceofhelicobacterpyloritofiveantibioticsandinfluencingfactorsinanareaofchinawithahighriskofgastriccancer
AT guoqianqian theantibioticresistanceofhelicobacterpyloritofiveantibioticsandinfluencingfactorsinanareaofchinawithahighriskofgastriccancer
AT yuanyuan theantibioticresistanceofhelicobacterpyloritofiveantibioticsandinfluencingfactorsinanareaofchinawithahighriskofgastriccancer
AT gongyuehua theantibioticresistanceofhelicobacterpyloritofiveantibioticsandinfluencingfactorsinanareaofchinawithahighriskofgastriccancer
AT wangdan antibioticresistanceofhelicobacterpyloritofiveantibioticsandinfluencingfactorsinanareaofchinawithahighriskofgastriccancer
AT guoqianqian antibioticresistanceofhelicobacterpyloritofiveantibioticsandinfluencingfactorsinanareaofchinawithahighriskofgastriccancer
AT yuanyuan antibioticresistanceofhelicobacterpyloritofiveantibioticsandinfluencingfactorsinanareaofchinawithahighriskofgastriccancer
AT gongyuehua antibioticresistanceofhelicobacterpyloritofiveantibioticsandinfluencingfactorsinanareaofchinawithahighriskofgastriccancer